HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delavirdine.

Source:http://linkedlifedata.com/resource/pubmed/id/9052722

J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997 Feb 1 14 2 136-44

Download in:

View as

Triples

General Info

PMID
9052722